Literature DB >> 1652582

A new antitumor substance BE-13793C, produced by a streptomycete. Taxonomy, fermentation, isolation, structure determination and biological activity.

K Kojiri1, H Kondo, T Yoshinari, H Arakawa, S Nakajima, F Satoh, K Kawamura, A Okura, H Suda, M Okanishi.   

Abstract

A new antitumor substance, BE-13793C, which has topoisomerase inhibitory activity was isolated from the culture broth of a strain of actinomycetes. The producing strain, BA13793, isolated from a soil sample collected in Seto, Aichi Prefecture, Japan, has a resemblance to Streptoverticillium mobaraense. The active principle was extracted from the mycelium of strain BA13793 with methanol and purified by Sephadex LH-20 column chromatography. BE-13793C showed strong inhibitory activity against topoisomerases I and II and inhibited the growth of doxorubicin-resistant or vincristine-resistant P388 murine leukemia cell lines, as well as their parent P388 cell line.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1652582     DOI: 10.7164/antibiotics.44.723

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  7 in total

1.  Arcyriaflavin E, a new cytotoxic indolocarbazole alkaloid isolated by combined-culture of mycolic acid-containing bacteria and Streptomyces cinnamoneus NBRC 13823.

Authors:  Shotaro Hoshino; Lihan Zhang; Takayoshi Awakawa; Toshiyuki Wakimoto; Hiroyasu Onaka; Ikuro Abe
Journal:  J Antibiot (Tokyo)       Date:  2014-10-22       Impact factor: 2.649

2.  Cytotoxic Indolocarbazoles from Actinomadura melliaura ATCC 39691.

Authors:  Khaled A Shaaban; Sherif I Elshahawi; Xiachang Wang; Jamie Horn; Madan K Kharel; Markos Leggas; Jon S Thorson
Journal:  J Nat Prod       Date:  2015-06-19       Impact factor: 4.050

3.  In vivo anti-tumor activity of a novel indolocarbazole compound, J-107088, on murine and human tumors transplanted into mice.

Authors:  H Arakawa; M Morita; T Kodera; A Okura; M Ohkubo; H Morishima; S Nishimura
Journal:  Jpn J Cancer Res       Date:  1999-10

4.  A Co-Culturing Approach Enables Discovery and Biosynthesis of a Bioactive Indole Alkaloid Metabolite.

Authors:  Fleurdeliz Maglangit; Qing Fang; Kwaku Kyeremeh; Jeremy M Sternberg; Rainer Ebel; Hai Deng
Journal:  Molecules       Date:  2020-01-08       Impact factor: 4.411

5.  Molecular Mechanisms of Anticancer Activity of N-Glycosides of Indolocarbazoles LCS-1208 and LCS-1269.

Authors:  Roman G Zenkov; Olga A Vlasova; Varvara P Maksimova; Timur I Fetisov; Natalia Y Karpechenko; Lidiya V Ektova; Vera A Eremina; Valeriia G Popova; Olga G Usalka; Ekaterina A Lesovaya; Gennady A Belitsky; Marianna G Yakubovskaya; Kirill I Kirsanov
Journal:  Molecules       Date:  2021-12-02       Impact factor: 4.411

6.  Antimetastatic effect of a novel indolocarbazole (NB-506) on IMC-HM murine tumor cells metastasized to the liver.

Authors:  H Arakawa; H Matsumoto; M Morita; M Sasaki; K Taguchi; A Okura; S Nishimura
Journal:  Jpn J Cancer Res       Date:  1996-05

7.  ED-110, a novel indolocarbazole, prevents the growth of experimental tumors in mice.

Authors:  H Arakawa; T Iguchi; T Yoshinari; K Kojiri; H Suda; A Okura
Journal:  Jpn J Cancer Res       Date:  1993-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.